These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31156789)

  • 1. Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids.
    Hatamipour M; Sahebkar A; Alavizadeh SH; Dorri M; Jaafari MR
    Iran J Basic Med Sci; 2019 Mar; 22(3):282-289. PubMed ID: 31156789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The enhanced bioavailability of free curcumin and bioactive-metabolite tetrahydrocurcumin from a dispersible, oleoresin-based turmeric formulation.
    Panda SK; Nirvanashetty S; Missamma M; Jackson-Michel S
    Medicine (Baltimore); 2021 Jul; 100(27):e26601. PubMed ID: 34232211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of oral bioavailability of curcuminoid dispersions and nanoemulsions prepared from Curcuma longa Linnaeus.
    Lu PS; Inbaraj BS; Chen BH
    J Sci Food Agric; 2018 Jan; 98(1):51-63. PubMed ID: 28516478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond Yellow Curry: Assessing Commercial Curcumin Absorption Technologies.
    Douglass BJ; Clouatre DL
    J Am Coll Nutr; 2015; 34(4):347-58. PubMed ID: 25856323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice.
    Zhongfa L; Chiu M; Wang J; Chen W; Yen W; Fan-Havard P; Yee LD; Chan KK
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):679-89. PubMed ID: 21968952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of Nanomicelles to Improve the Solubility and the Oral Absorption of Silymarin.
    Piazzini V; D'Ambrosio M; Luceri C; Cinci L; Landucci E; Bilia AR; Bergonzi MC
    Molecules; 2019 Apr; 24(9):. PubMed ID: 31052197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Formulation of Curcuminoids on Their Metabolism by Human Colonic Microbiota.
    Bresciani L; Favari C; Calani L; Francinelli V; Riva A; Petrangolini G; Allegrini P; Mena P; Del Rio D
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32093121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PNIPAM nanoparticles for targeted and enhanced nose-to-brain delivery of curcuminoids: UPLC/ESI-Q-ToF-MS/MS-based pharmacokinetics and pharmacodynamic evaluation in cerebral ischemia model.
    Ahmad N; Ahmad I; Umar S; Iqbal Z; Samim M; Ahmad FJ
    Drug Deliv; 2016 Sep; 23(7):2095-2114. PubMed ID: 25237726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability studies of pure and mixture form of curcuminoids by reverse phase-HPLC method under various experimental stress conditions.
    Peram MR; Jalalpure SS; Palkar MB; Diwan PV
    Food Sci Biotechnol; 2017; 26(3):591-602. PubMed ID: 30263583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral Concentrations and Effects of Orally Administered Micellar Curcuminoids in Glioblastoma Patients.
    Dützmann S; Schiborr C; Kocher A; Pilatus U; Hattingen E; Weissenberger J; Geßler F; Quick-Weller J; Franz K; Seifert V; Frank J; Senft C
    Nutr Cancer; 2016; 68(6):943-8. PubMed ID: 27340742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential solubility of curcuminoids in serum and albumin solutions: implications for analytical and therapeutic applications.
    Quitschke WW
    BMC Biotechnol; 2008 Nov; 8():84. PubMed ID: 18990234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bioavailability of curcuminoids from a water-dispersible high curcuminoid turmeric extract against a generic turmeric extract: a randomized, cross-over, comparative, pharmacokinetic study.
    Thanawala S; Shah R; Alluri KV; Somepalli V; Vaze S; Upadhyay V
    J Pharm Pharmacol; 2021 Apr; 73(6):816-823. PubMed ID: 33755149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Oral Formulation and in Vitro Evaluation of Docetaxel-Loaded Nanomicelles.
    Hekmat A; Attar H; Seyf Kordi AA; Iman M; Jaafari MR
    Molecules; 2016 Sep; 21(9):. PubMed ID: 27657038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of modified ε-polylysine micelles and their application in improving cellular antioxidant activity of curcuminoids.
    Yu H; Li J; Shi K; Huang Q
    Food Funct; 2011 Jul; 2(7):373-80. PubMed ID: 21894323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles.
    Tiyaboonchai W; Tungpradit W; Plianbangchang P
    Int J Pharm; 2007 Jun; 337(1-2):299-306. PubMed ID: 17287099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and pharmacokinetic studies of curcumin, demethoxycurcumin and bisdemethoxycurcumin in mice tumor after intragastric administration of nanoparticle formulations by liquid chromatography coupled with tandem mass spectrometry.
    Li R; Qiao X; Li Q; He R; Ye M; Xiang C; Lin X; Guo D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(26):2751-8. PubMed ID: 21856253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of a Sustained Release Formulation of Curcumin.
    Madhavi D; Kagan D
    Integr Med (Encinitas); 2014 Jun; 13(3):24-30. PubMed ID: 26770097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Effects of Minor Components of Curcuminoids on Hydrogen Peroxide-Treated Human HaCaT Keratinocytes.
    Liu YH; Lin YS; Huang YW; Fang SU; Lin SY; Hou WC
    J Agric Food Chem; 2016 May; 64(18):3598-608. PubMed ID: 27094403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Water Dispersibility of Curcumin Encapsulated in Alginate-Polysorbate 80 Nano Particles and Bioavailability in Healthy Human Volunteers.
    Govindaraju R; Karki R; Chandrashekarappa J; Santhanam M; Shankar AKK; Joshi HK; Divakar G
    Pharm Nanotechnol; 2019; 7(1):39-56. PubMed ID: 30666922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility.
    Vadlapudi AD; Cholkar K; Vadlapatla RK; Mitra AK
    J Ocul Pharmacol Ther; 2014 Feb; 30(1):49-58. PubMed ID: 24192229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.